LOS ANGELES, July 09, 2025 (GLOBE NEWSWIRE) -- Trethera Corporation (“Trethera”), a clinical stage biopharmaceutical company developing first-in-class therapies for cancer and autoimmune diseases, ...

New ‘gentler’ treatment for prostate cancer gets green light but not all men will have access to it - It comes as concerns ...

NEW HAVEN, Conn., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Halda Therapeutics, a clinical-stage biotechnology company developing a novel class of therapies called RIPTAC™ Therapeutics, today announced that ...

Biden’s personal office revealed in May that he had been diagnosed with an “aggressive form” of prostate cancer that had ...

Survivorship in metastatic prostate cancer is seen as chronic management, focusing on quality of life through physical and emotional management. Carotuximab combined with Erleada shows a favorable ...

Darolutamide, also known as Nubeqa and made by Bayer, is recommended in final draft guidance to treat adults with metastatic hormone-sensitive prostate cancer in combination with androgen deprivation ...

Prostate cancer screening for men over 70 is complex, with current recommendations against routine PSA testing due to slow ...

“As part of a treatment plan for prostate cancer, President Biden is currently undergoing radiation therapy and hormone ...

In preclinical prostate cancer models, HLD-0915 treatment resulted in tumor shrinkage and declines in prostate-specific antigen. The Food and Drug Administration (FDA) has granted Fast Track ...

Prostate cancer is the most common form of cancer in the UK, according to Prostate Cancer UK. Cancer Research UK says ...

Dr. Ravi Munver explained that, for patients who are recently diagnosed with prostate cancer, it is important to explore treatment option with their care. It is important for patients who are recently ...

Find out how the NHS is using AI to diagnose prostate cancer faster, potentially improving outcomes for thousands of men ...